FIELD: medicine; pharmacology.
SUBSTANCE: proposed suppository along with consistent base (lipophilic, hydrophilic or diphilic) and stabiliser selected from chlorhexidine bigluconate, nypagine and sodium carboxymethyl cellulose as natural endogenous interferon inductor, is supplied with sodium salt complex of alpha-helical and double-helical RNA from killer yeast Saccharomyces cerevisiae. Quantitative amount of specified ingredients per suppository of mass 1.0 g is: sodium salt complex of alpha-helical and double-helical RNA from killer yeast Saccharomyces cerevisiae - 50-150 mcg; stabiliser - 10-30 mcg; additives - others.
EFFECT: extended range of therapeutic antiviral agents and reduced toxicity with maintained efficiency.
6 cl, 4 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
PROLONGED-EFFECT INTERFERON INDUCTOR | 1999 |
|
RU2172631C2 |
ANTIVIRAL AGENT | 1996 |
|
RU2123339C1 |
INTRANASAL ANTIVIRAL AGENT | 2023 |
|
RU2833350C1 |
METHOD FOR TREATMENT AND PROPHYLAXIS OF GASTROINTESTINAL INFECTION DISEASE IN PIGLETS UNDER CONDITION OF INDUSTRIAL SWINE BREEDING | 2004 |
|
RU2272632C2 |
METHOD FOR PRODUCING BIOLOGICALLY ACTIVE COMPONENTS FROM YEAST CELLS SACCHAROMYCES CEREVISIAE AND A THERAPEUTIC AGENT BASED THEREON | 2018 |
|
RU2722731C2 |
ANTIHERPETIC AGENT | 2012 |
|
RU2502504C1 |
AGENT FOR TREATING AND PREVENTING VIRAL SKIN NEW GROWTHS | 2014 |
|
RU2574953C1 |
ANTICANCER DRUG BASED ON NANOPARTICLES BEARING RECOMBINANT HUMAN TUMOUR NECROSIS FACTOR ALPHA | 2008 |
|
RU2386447C1 |
RIDOSTIN AS INTERFERON INDUCTOR | 1993 |
|
RU2083221C1 |
ANTITUMOUR AGENT BASED ON BIODEGRADABLE NANOPARTICLES CARRYING A RECOMBINANT HUMAN TUMOR NECROSIS FACTOR ALPHA | 2018 |
|
RU2691938C1 |
Authors
Dates
2008-07-10—Published
2005-03-22—Filed